FDA Discusses Manufacturing Processes In ARB Medicines Impurities Update

  
Flashlight
FDA's investigations point to changes in manufacturing processes potentially leading to impurities • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Generics

More from Products